The promising anticancer drug 3-bromopyruvate is metabolized through glutathione conjugation which affects chemoresistance and clinical practice: An evidence-based view
- Resource Type
- Article
- Source
- In
Medical Hypotheses March 2017 100:67-77 - Subject
- Language
- ISSN
- 0306-9877